The company was founded in 2022 and is based in Minneapolis, Minnesota. Enterra Medical focuses on advancing technology, expanding clinical science, and accelerating access to its Enterra™ Therapy, the first and only implantable therapy for Gastric Electrical Stimulation approved by the FDA under a Humanitarian Device Exemption in 2000. The therapy may be a surgical option for certain people who are unable to control chronic symptoms of gastroparesis. Enterra Medical has assumed ongoing responsibility of Enterra Therapy from Medtronic to increase investment and focus on the therapy. Medtronic remains a strong operational partner in this new management model and will continue to handle customer and patient support until Enterra Medical is fully equipped to assume those functions.